The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Management of Insomnia | New England Journal of Medicine
2024年7月17日 · Insomnia is common and frequently occurs with other disorders. First-line cognitive behavioral therapy with or without medication can produce rapid, sustained …
Hydrocortisone in Severe Community-Acquired Pneumonia | New …
2023年3月21日 · New perspectives on community-acquired pneumonia in 388 406 patients: results from a nationwide mandatory performance measurement programme in healthcare …
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH …
2024年2月7日 · From the University of Oxford, Oxford (S.A.H.), the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne …
Dapagliflozin in Patients with Chronic Kidney Disease | New …
2020年9月24日 · Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, …
Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis
2022年9月14日 · A total of 249 patients were included in the interim analysis. The trial was halted owing to between-group differences in the safety outcomes without a significant difference in …
Defibrillation Strategies for Refractory Ventricular Fibrillation | New ...
2022年11月6日 · Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external …
Critical Illness in an Adolescent with Influenza A(H5N1) Virus ...
2024年12月31日 · On November 4, 2024, a 13-year-old girl with a history of mild asthma and an elevated body-mass index (the weight in kilograms divided by the square of the height in …
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ...
2024年6月14日 · New England Journal of Medicine. Volume 391 • Number 3 • July 18 ... VIC (B.C.V.C), and the Department of Neurology, University of New South Wales South Western …
Efficacy and Safety of Acoramidis in Transthyretin Amyloid ...
2024年1月10日 · Most of the patients had either New York Heart Association (NYHA) class II symptoms (72.0%) or class III symptoms (17.2%). The distribution of National Amyloidosis …